These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 10469608)

  • 1. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase.
    Ganther HE
    Carcinogenesis; 1999 Sep; 20(9):1657-66. PubMed ID: 10469608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.
    Arnér ES
    Biochim Biophys Acta; 2009 Jun; 1790(6):495-526. PubMed ID: 19364476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
    Anestål K; Arnér ES
    J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro.
    Ganther H; Ip C
    J Nutr; 2001 Feb; 131(2):301-4. PubMed ID: 11160550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress in physiological functions of selenoenzyme and other selenocompounds].
    Huang Z; Xiang JJ; Guo BJ
    Sheng Li Ke Xue Jin Zhan; 2001 Oct; 32(4):293-7. PubMed ID: 12545853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium and the thioredoxin redox system: effects on cell growth and death.
    Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
    Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium, selenoproteins and human health: a review.
    Brown KM; Arthur JR
    Public Health Nutr; 2001 Apr; 4(2B):593-9. PubMed ID: 11683552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox regulation of protein kinase C by selenometabolites and selenoprotein thioredoxin reductase limits cancer prevention by selenium.
    Gopalakrishna R; Gundimeda U; Zhou S; Bui H; Holmgren A
    Free Radic Biol Med; 2018 Nov; 127():55-61. PubMed ID: 29775743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium compounds and selenoproteins in cancer.
    Brigelius-Flohé R
    Chem Biodivers; 2008 Mar; 5(3):389-95. PubMed ID: 18357548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase.
    Lu J; Berndt C; Holmgren A
    Biochim Biophys Acta; 2009 Nov; 1790(11):1513-9. PubMed ID: 19406206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium in cancer prevention: a review of the evidence and mechanism of action.
    Rayman MP
    Proc Nutr Soc; 2005 Nov; 64(4):527-42. PubMed ID: 16313696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
    Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
    Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking mercury: the role of selenium in the pathophysiology of mercury toxicity.
    Spiller HA
    Clin Toxicol (Phila); 2018 May; 56(5):313-326. PubMed ID: 29124976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
    Ip C; Thompson HJ; Zhu Z; Ganther HE
    Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells.
    Lü J; Jiang C
    Antioxid Redox Signal; 2005; 7(11-12):1715-27. PubMed ID: 16356132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negation of the cancer-preventive actions of selenium by over-expression of protein kinase Cepsilon and selenoprotein thioredoxin reductase.
    Gundimeda U; Schiffman JE; Gottlieb SN; Roth BI; Gopalakrishna R
    Carcinogenesis; 2009 Sep; 30(9):1553-61. PubMed ID: 19578042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular thioredoxin reductase activity is regulated by selenium.
    Berggren M; Gallegos A; Gasdaska J; Powis G
    Anticancer Res; 1997; 17(5A):3377-80. PubMed ID: 9413175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of selenium in thyroid autoimmunity and cancer.
    Duntas LH
    Thyroid; 2006 May; 16(5):455-60. PubMed ID: 16756467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.
    Rundlöf AK; Arnér ES
    Antioxid Redox Signal; 2004 Feb; 6(1):41-52. PubMed ID: 14980055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.